Samsung BioLogics Says Report On Biogen Deal Talks Untrue

Samsung BioLogics Says Report On Biogen Deal Talks Untrue

  (Reuters) -Samsung BioLogics on Thursday denied a media report that said the South Korean firm was in talks to buy U.S. drugmaker Biogen Inc. Korea Economic Daily reported https://www.kedglobal.com/newsView/ked202112290011?lang=us on Wednesday, citing investment banking sources, that Biogen had approached Samsung to buy its shares, which could be valued at more than $42 billion. Biogen…

Read More